Item 1. Financial Statements
53K characters. Original on sec.gov ·
Item 1. Financial Statements
Condensed Consolidated Balance Sheets
$ in millions, except per share amounts (unaudited)
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||
| Assets | |||||||||||||||||
| Current assets | |||||||||||||||||
| Cash and cash equivalents | $ | 1,749 | $ | 1,738 | $ | 1,147 | |||||||||||
| Receivables, net | 906 | 1,043 | 744 | ||||||||||||||
| Merchandise inventories | 5,598 | 5,230 | 5,194 | ||||||||||||||
| Other current assets | 487 | 493 | 500 | ||||||||||||||
| Total current assets | 8,740 | 8,504 | 7,585 | ||||||||||||||
| Property and equipment, net | 1,987 | 1,986 | 2,089 | ||||||||||||||
| Operating lease assets | 2,870 | 2,869 | 2,821 | ||||||||||||||
| Goodwill | 790 | 790 | 908 | ||||||||||||||
| Other assets | 503 | 521 | 725 | ||||||||||||||
| Total assets | $ | 14,890 | $ | 14,670 | $ | 14,128 | |||||||||||
| Liabilities and equity | |||||||||||||||||
| Current liabilities | |||||||||||||||||
| Accounts payable | $ | 5,118 | $ | 4,745 | $ | 4,670 | |||||||||||
| Unredeemed gift card liabilities | 229 | 235 | 246 | ||||||||||||||
| Deferred revenue | 843 | 900 | 891 | ||||||||||||||
| Accrued compensation and related expenses | 317 | 423 | 367 | ||||||||||||||
| Accrued liabilities | 665 | 742 | 617 | ||||||||||||||
| Current portion of operating lease liabilities | 614 | 623 | 611 | ||||||||||||||
| Current portion of long-term debt | 11 | 11 | 10 | ||||||||||||||
| Total current liabilities | 7,797 | 7,679 | 7,412 | ||||||||||||||
| Long-term operating lease liabilities | 2,343 | 2,334 | 2,277 | ||||||||||||||
| Long-term debt | 1,158 | 1,165 | 1,153 | ||||||||||||||
| Long-term liabilities | 509 | 528 | 523 | ||||||||||||||
| Contingencies (Note 10) | |||||||||||||||||
| Equity | |||||||||||||||||
| Best Buy Co., Inc. Shareholders' Equity | |||||||||||||||||
| Preferred stock, $1.00 par value: Authorized - 400,000 shares; Issued and outstanding - none | - | - | - | ||||||||||||||
| Common stock, $0.10 par value: Authorized - 1.0 billion shares; Issued and outstanding - 210.7 million, 209.1 million and 211.3 million shares, respectively | 22 | 22 | 22 | ||||||||||||||
| Additional paid-in capital | 65 | 14 | - | ||||||||||||||
| Retained earnings | 2,677 | 2,610 | 2,428 | ||||||||||||||
| Accumulated other comprehensive income | 319 | 318 | 313 | ||||||||||||||
| Total equity | 3,083 | 2,964 | 2,763 | ||||||||||||||
| Total liabilities and equity | $ | 14,890 | $ | 14,670 | $ | 14,128 |
NOTE: The Consolidated Balance Sheet as of January 31, 2026, has been condensed from the audited consolidated financial statements.
See Notes to Condensed Consolidated Financial Statements.
Condensed Consolidated Statements of Earnings
$ and shares in millions, except per share amounts (unaudited)
| Three Months Ended | |||||||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||||||
| Revenue | $ | 8,936 | $ | 8,767 | |||||||||||||||||||
| Cost of sales | 6,834 | 6,718 | |||||||||||||||||||||
| Gross profit | 2,102 | 2,049 | |||||||||||||||||||||
| Selling, general and administrative expenses | 1,741 | 1,721 | |||||||||||||||||||||
| Restructuring charges | (9) | 109 | |||||||||||||||||||||
| Operating income | 370 | 219 | |||||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||
| Investment income and other | 19 | 15 | |||||||||||||||||||||
| Interest expense | (11) | (12) | |||||||||||||||||||||
| Earnings before income tax expense and equity in loss of affiliates | 378 | 222 | |||||||||||||||||||||
| Income tax expense | 102 | 19 | |||||||||||||||||||||
| Equity in loss of affiliates | - | (1) | |||||||||||||||||||||
| Net earnings | $ | 276 | $ | 202 | |||||||||||||||||||
| Basic earnings per share | $ | 1.31 | $ | 0.95 | |||||||||||||||||||
| Diluted earnings per share | $ | 1.31 | $ | 0.95 | |||||||||||||||||||
| Weighted-average common shares outstanding: | |||||||||||||||||||||||
| Basic | 210.4 | 212.0 | |||||||||||||||||||||
| Diluted | 211.3 | 213.0 |
See Notes to Condensed Consolidated Financial Statements.
Condensed Consolidated Statements of Comprehensive Income
$ in millions (unaudited)
| Three Months Ended | |||||||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||||||
| Net earnings | $ | 276 | $ | 202 | |||||||||||||||||||
| Foreign currency translation adjustments, net of tax | 1 | 13 | |||||||||||||||||||||
| Comprehensive income | $ | 277 | $ | 215 |
See Notes to Condensed Consolidated Financial Statements.
Condensed Consolidated Statements of Cash Flows
$ in millions (unaudited)
| Three Months Ended | |||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||
| Operating activities | |||||||||||
| Net earnings | $ | 276 | $ | 202 | |||||||
| Adjustments to reconcile net earnings to total cash provided by operating activities: | |||||||||||
| Depreciation and amortization | 194 | 211 | |||||||||
| Restructuring charges | (9) | 109 | |||||||||
| Stock-based compensation | 40 | 40 | |||||||||
| Deferred income taxes | 10 | (51) | |||||||||
| Other, net | 1 | (2) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Receivables | 138 | 298 | |||||||||
| Merchandise inventories | (367) | (95) | |||||||||
| Other assets | 12 | 7 | |||||||||
| Accounts payable | 349 | (330) | |||||||||
| Income taxes | 42 | 7 | |||||||||
| Other liabilities | (311) | (362) | |||||||||
| Total cash provided by operating activities | 375 | 34 | |||||||||
| Investing activities | |||||||||||
| Additions to property and equipment | (160) | (166) | |||||||||
| Total cash used in investing activities | (160) | (166) | |||||||||
| Financing activities | |||||||||||
| Repurchase of common stock | - | (100) | |||||||||
| Dividends paid | (202) | (202) | |||||||||
| Other, net | - | (3) | |||||||||
| Total cash used in financing activities | (202) | (305) | |||||||||
| Effect of exchange rate changes on cash and cash equivalents | - | 4 | |||||||||
| Increase (decrease) in cash, cash equivalents and restricted cash | 13 | (433) | |||||||||
| Cash, cash equivalents and restricted cash at beginning of period | 2,023 | 1,868 | |||||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 2,036 | $ | 1,435 |
See Notes to Condensed Consolidated Financial Statements.
Condensed Consolidated Statements of Changes in Shareholders' Equity
$ and shares in millions, except per share amounts (unaudited)
| Common Shares | Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income | Total | ||||||||||||||||||||||||||||||
| Balances at January 31, 2026 | 209.1 | $ | 22 | $ | 14 | $ | 2,610 | $ | 318 | $ | 2,964 | ||||||||||||||||||||||||
| Net earnings, three months ended May 2, 2026 | - | - | - | 276 | - | 276 | |||||||||||||||||||||||||||||
| Other comprehensive income: | |||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | - | - | - | - | 1 | 1 | |||||||||||||||||||||||||||||
| Stock-based compensation | - | - | 40 | - | - | 40 | |||||||||||||||||||||||||||||
| Issuance of common stock | 1.6 | - | 4 | - | - | 4 | |||||||||||||||||||||||||||||
| Common stock dividends, $0.96 per share | - | - | 7 | (209) | - | (202) | |||||||||||||||||||||||||||||
| Balances at May 2, 2026 | 210.7 | $ | 22 | $ | 65 | $ | 2,677 | $ | 319 | $ | 3,083 | ||||||||||||||||||||||||
| Balances at February 1, 2025 | 211.4 | $ | 22 | $ | - | $ | 2,486 | $ | 300 | $ | 2,808 | ||||||||||||||||||||||||
| Net earnings, three months ended May 3, 2025 | - | - | - | 202 | - | 202 | |||||||||||||||||||||||||||||
| Other comprehensive income: | |||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments, net of tax | - | - | - | - | 13 | 13 | |||||||||||||||||||||||||||||
| Stock-based compensation | - | - | 40 | - | - | 40 | |||||||||||||||||||||||||||||
| Issuance of common stock | 1.5 | - | 2 | - | - | 2 | |||||||||||||||||||||||||||||
| Common stock dividends, $0.95 per share | - | - | 6 | (208) | - | (202) | |||||||||||||||||||||||||||||
| Repurchase of common stock | (1.6) | - | (48) | (52) | - | (100) | |||||||||||||||||||||||||||||
| Balances at May 3, 2025 | 211.3 | $ | 22 | $ | - | $ | 2,428 | $ | 313 | $ | 2,763 |
See Notes to Condensed Consolidated Financial Statements.
Notes to Condensed Consolidated Financial Statements
(unaudited)
1. Basis of Presentation
Unless the context otherwise requires, the terms “Best Buy,” “we,” “us,” “our” and the “company” in these Notes to Condensed Consolidated Financial Statements refer to Best Buy Co., Inc. and, as applicable, its consolidated subsidiaries.
In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments necessary for a fair presentation as prescribed by accounting principles generally accepted in the U.S. (“GAAP”). All adjustments were comprised of normal recurring adjustments, except as noted in these Notes to Condensed Consolidated Financial Statements.
A large proportion of our revenue and earnings is generated in the fiscal fourth quarter, which includes the majority of the holiday shopping season. Due to the seasonal nature of our business, interim results are not necessarily indicative of results for the entire fiscal year. The interim financial statements and the related notes included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2026. The first three months of fiscal 2027 and fiscal 2026 each included 13 weeks. Unless otherwise noted, references to years in these notes to condensed consolidated financial statements relate to fiscal years, not calendar years.
In preparing the accompanying condensed consolidated financial statements, we evaluated the period from May 2, 2026, through the date the financial statements were issued for material subsequent events requiring recognition or disclosure. No such events were identified.
Unadopted Accounting Pronouncements
In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of specific expense categories in the notes to financial statements. The amendments are effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. We are currently evaluating the impact of the ASU and expect to include updated expense disclosures in our fiscal 2028 Form 10-K.
Supply Chain Financing
We have a supply chain financing program with an independent financial institution, whereby some of our suppliers have the opportunity to receive accounts payable settlements early, at a discount, facilitated by the financial institution. Our liability associated with the funded participation in the program, which is primarily included in Accounts payable on our Condensed Consolidated Balance Sheets, was $861 million, $600 million and $569 million as of May 2, 2026, January 31, 2026, and May 3, 2025, respectively.
Total Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash reported on our Condensed Consolidated Balance Sheets are reconciled to the totals shown on our Condensed Consolidated Statements of Cash Flows as follows ($ in millions):
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||
| Cash and cash equivalents | $ | 1,749 | $ | 1,738 | $ | 1,147 | |||||||||||
| Restricted cash included in Other current assets | 287 | 285 | 288 | ||||||||||||||
| Total cash, cash equivalents and restricted cash | $ | 2,036 | $ | 2,023 | $ | 1,435 |
Amounts included in restricted cash are primarily restricted to cover product protection plans provided under our membership offerings and self-insurance liabilities.
2. Restructuring
Restructuring charges were as follows ($ in millions):
| Three Months Ended | |||||||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||||||
| Fiscal 2026 Labor and Store Optimization Initiative | $ | (8) | $ | - | |||||||||||||||||||
| Best Buy Health Optimization and China Sourcing Initiative | (1) | 111 | |||||||||||||||||||||
| Fiscal 2024 Restructuring Initiative | - | (2) | |||||||||||||||||||||
| Total | $ | (9) | $ | 109 |
Fiscal 2026 Labor and Store Optimization Initiative
In the second quarter of fiscal 2026, we commenced a restructuring initiative intended to align field resources with changing customer behaviors, close select non-traditional store locations and redirect corporate resources for better alignment with our strategy. We currently do not expect to incur material future restructuring charges related to this initiative.
All charges incurred related to this initiative were from continuing operations and presented within Restructuring charges on our Condensed Consolidated Statements of Earnings. The composition of restructuring charges incurred related to this initiative were as follows ($ in millions):
| Three Months Ended May 2, 2026 | Cumulative Amount as of May 2, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domestic | Domestic | International | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Termination benefits | $ | (7) | $ | 61 | $ | 3 | $ | 64 | |||||||||||||||||||||||||||||||||||||||||||||
| Asset impairments and other costs(1) | (1) | 45 | - | 45 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total | $ | (8) | $ | 106 | $ | 3 | $ | 109 |
(1)Cumulative amount as of May 2, 2026 primarily represents asset impairments related to planned store closures, an impairment related to an indefinite-lived tradename and other exit costs. The remaining carrying value of net assets approximates fair value and was immaterial as of May 2, 2026.
Restructuring accrual activity related to this initiative was as follows ($ in millions):
| Termination Benefits | |||||||||||||||||
| Domestic | International | Total | |||||||||||||||
| Balances at January 31, 2026 | $ | 42 | $ | 3 | $ | 45 | |||||||||||
| Cash payments | (8) | (1) | (9) | ||||||||||||||
| Adjustments(1) | (7) | - | (7) | ||||||||||||||
| Balances at May 2, 2026 | $ | 27 | $ | 2 | $ | 29 |
(1)Represents adjustments primarily related to higher-than-expected employee retention from previously planned organizational changes.
Our restructuring accrual liabilities primarily related to termination benefits of $29 million as of May 2, 2026, reflect expected future cash payments primarily during fiscal 2027 and fiscal 2028.
Best Buy Health Optimization and China Sourcing Initiative
In the first quarter of fiscal 2026, we commenced a restructuring initiative primarily focused on optimizing our Best Buy Health business by taking actions to maximize value and improve profitability in light of its performance against our original forecasting. These actions included the exit of a component of our Best Buy Health business that was finalized during the second quarter of fiscal 2026. In addition, we also made significant changes to reduce our exposure to tariffs, particularly in China. We currently do not expect to incur material future restructuring charges related to this initiative and no material liability remains as of May 2, 2026.
Fiscal 2024 Restructuring Initiative
During the fourth quarter of fiscal 2024, we commenced an enterprise-wide restructuring initiative intended to align field labor resources with where customers want to shop and to optimize the customer experience, redirect corporate resources for better alignment with our strategy and right-size resources to better align with our revenue outlook for fiscal 2025. There were no expenses incurred related to this initiative in the first quarter of fiscal 2027, and we do not expect to incur material future restructuring charges related to this initiative.
The only remaining restructuring accrual related to this initiative relates to our Domestic segment and was as follows ($ in millions):
| Termination Benefits | |||||||||||||||||
| Balance at January 31, 2026 | $ | 31 | |||||||||||||||
| Cash payments | (1) | ||||||||||||||||
| Balance at May 2, 2026 | $ | 30 |
Our restructuring accrual liability related to termination benefits of $30 million as of May 2, 2026, reflects expected future cash payments primarily during fiscal 2028.
3. Goodwill
Goodwill balances by segment were as follows ($ in millions):
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||||||||||||||||||||
| Gross Carrying Amount | Cumulative Impairment | Gross Carrying Amount | Cumulative Impairment (1) | Gross Carrying Amount | Cumulative Impairment | ||||||||||||||||||||||||||||||
| Domestic | $ | 1,450 | $ | (660) | $ | 1,450 | $ | (660) | $ | 1,450 | $ | (542) | |||||||||||||||||||||||
| International | 608 | (608) | 608 | (608) | 608 | (608) | |||||||||||||||||||||||||||||
| Total | $ | 2,058 | $ | (1,268) | $ | 2,058 | $ | (1,268) | $ | 2,058 | $ | (1,150) |
(1)In the third quarter of fiscal 2026, we recorded a goodwill impairment of $118 million within the Domestic segment for the Best Buy Health reporting unit.
4. Fair Value Measurements
Recurring Fair Value Measurements
Financial assets and liabilities accounted for at fair value were as follows ($ in millions):
| Fair Value as of | |||||||||||||||||||||||||||||
| Balance Sheet Location**(1)** | Fair Value Hierarchy | May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||
| Money market funds(2) | Cash and cash equivalents | Level 1 | $ | 77 | $ | 143 | $ | 79 | |||||||||||||||||||||
| Time deposits(3) | Cash and cash equivalents | Level 2 | 200 | 252 | 232 | ||||||||||||||||||||||||
| Commercial paper(2) | Cash and cash equivalents | Level 2 | - | 37 | - | ||||||||||||||||||||||||
| Money market funds(2) | Other current assets | Level 1 | 124 | 123 | 142 | ||||||||||||||||||||||||
| Time deposits(3) | Other current assets | Level 2 | 30 | 30 | 50 | ||||||||||||||||||||||||
| Marketable securities that fund deferred compensation(4) | Other assets | Level 1 | 41 | 41 | 38 | ||||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||
| Interest rate swap derivative instruments(5) | Long-term liabilities | Level 2 | 8 | 1 | 8 |
(1)Balance sheet location is determined by the length to maturity at date of purchase and whether the assets are restricted for particular use.
(2)Valued at quoted market prices in active markets at period end.
(3)Valued at face value plus accrued interest at period end, which approximates fair value.
(4)Valued using the performance of mutual funds that trade with sufficient frequency and volume to obtain pricing information on an ongoing basis.
(5)Valued using readily observable market inputs. These instruments are custom, over-the-counter contracts with various bank counterparties that are not traded on an active market. See Note 5, Derivative Instruments, for additional information.
Nonrecurring Fair Value Measurements
In the first quarter of fiscal 2026, we recorded asset impairments and other costs related to our Best Buy Health Optimization and China Sourcing Initiative. These nonrecurring fair value remeasurements were based on significant unobservable inputs (Level 3). Refer to Note 2, Restructuring, for additional information.
Fair Value of Financial Instruments
Long-term debt is presented at carrying value on our Condensed Consolidated Balance Sheets. If our long-term debt were recorded at fair value, it would be classified as Level 2 in the fair value hierarchy. Long-term debt balances were as follows ($ in millions):
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||||||||||||||||||||
| Fair Value | Carrying Value | Fair Value | Carrying Value | Fair Value | Carrying Value | ||||||||||||||||||||||||||||||
| Long-term debt(1) | $ | 1,075 | $ | 1,142 | $ | 1,089 | $ | 1,149 | $ | 1,043 | $ | 1,142 |
(1)Excludes debt discounts, issuance costs and finance lease obligations.
5. Derivative Instruments
The net notional amounts of our derivative instruments were as follows ($ in millions):
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||
| Derivatives designated as net investment hedges | $ | 119 | $ | 119 | $ | 119 | |||||||||||
| Derivatives designated as fair value hedges (interest rate swaps) | 500 | 500 | 500 | ||||||||||||||
| No hedge designation (foreign exchange contracts) | 31 | 34 | 54 | ||||||||||||||
| Total | $ | 650 | $ | 653 | $ | 673 |
Effects of our fair value hedges included in Interest expense on our Condensed Consolidated Statements of Earnings were as follows ($ in millions):
| Gain (Loss) Recognized | |||||||||||||||||||||||||||||
| Three Months Ended | |||||||||||||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||||||||||||
| Interest rate swaps | $ | (7) | $ | 6 | |||||||||||||||||||||||||
| Adjustments to carrying value of long-term debt | 7 | (6) | |||||||||||||||||||||||||||
| Total | $ | - | $ | - |
6. Debt
Short-Term Debt
U.S. Revolving Credit Facility
We have a $1.25 billion five-year senior unsecured revolving credit facility agreement (the “Five-Year Facility Agreement”) with a syndicate of banks that expires in April 2030. There were no borrowings outstanding under the Five-Year Facility Agreement as of May 2, 2026, January 31, 2026, or May 3, 2025.
Long-Term Debt
Long-term debt consisted of the following ($ in millions):
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||
| Notes, 4.45%, due October 1, 2028 ("2028 Notes") | $ | 500 | $ | 500 | $ | 500 | |||||||||||
| Notes, 1.95%, due October 1, 2030 ("2030 Notes") | 650 | 650 | 650 | ||||||||||||||
| Interest rate swap valuation adjustments | (8) | (1) | (8) | ||||||||||||||
| Subtotal | 1,142 | 1,149 | 1,142 | ||||||||||||||
| Debt discounts and issuance costs | (5) | (5) | (6) | ||||||||||||||
| Finance lease obligations | 32 | 32 | 27 | ||||||||||||||
| Total long-term debt | 1,169 | 1,176 | 1,163 | ||||||||||||||
| Less current portion | 11 | 11 | 10 | ||||||||||||||
| Total long-term debt, less current portion | $ | 1,158 | $ | 1,165 | $ | 1,153 |
Fair Value and Future Maturities
See Note 4, Fair Value Measurements, for the fair value of long-term debt. The 2028 Notes mature in fiscal 2029 and the 2030 Notes mature in fiscal 2031.
7. Revenue
We generate most of our revenue from contracts with customers from the sale of products and services. Contract balances primarily relate to unfulfilled membership benefits and services not yet completed, product merchandise not yet delivered to customers, unredeemed gift cards and deferred revenue from our private label and co-branded credit card arrangement. Contract balances were as follows ($ in millions):
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||
| Receivables, net(1) | $ | 528 | $ | 538 | $ | 461 | |||||||||||
| Short-term contract liabilities included in: | |||||||||||||||||
| Unredeemed gift card liabilities | 229 | 235 | 246 | ||||||||||||||
| Deferred revenue | 843 | 900 | 891 | ||||||||||||||
| Accrued liabilities | 64 | 57 | 59 | ||||||||||||||
| Long-term contract liabilities included in: | |||||||||||||||||
| Long-term liabilities | 197 | 205 | 221 |
(1)Receivables are recorded net of allowances for expected credit losses of $13 million, $17 million and $15 million as of May 2, 2026, January 31, 2026, and May 3, 2025, respectively.
During the first three months of fiscal 2027 and fiscal 2026, $569 million and $614 million of revenue was recognized, respectively, that was included in the contract liabilities at the beginning of the respective periods.
Estimated revenue from our contract liability balances expected to be recognized in future periods if the performance of the contract is expected to have an initial duration of more than one year is as follows ($ in millions):
| Fiscal Year | Amount | ||||
| Remainder of fiscal 2027 | $ | 27 | |||
| Fiscal 2028 | 33 | ||||
| Fiscal 2029 | 29 | ||||
| Fiscal 2030 | 28 | ||||
| Fiscal 2031 | 27 | ||||
| Fiscal 2032 | 26 | ||||
| Thereafter | 63 |
See Note 11, Segments, for information on our revenue by segment and category.
8. Earnings per Share
Reconciliations of the numerators and denominators of basic and diluted earnings per share were as follows ($ and shares in millions, except per share amounts):
| Three Months Ended | |||||||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||||||
| Numerator | |||||||||||||||||||||||
| Net earnings | $ | 276 | $ | 202 | |||||||||||||||||||
| Denominator | |||||||||||||||||||||||
| Weighted-average common shares outstanding | 210.4 | 212.0 | |||||||||||||||||||||
| Dilutive effect of stock compensation plan awards | 0.9 | 1.0 | |||||||||||||||||||||
| Weighted-average common shares outstanding, assuming dilution | 211.3 | 213.0 | |||||||||||||||||||||
| Potential shares which were anti-dilutive and excluded from weighted-average share computations | 1.7 | 0.3 | |||||||||||||||||||||
| Basic earnings per share | $ | 1.31 | $ | 0.95 | |||||||||||||||||||
| Diluted earnings per share | $ | 1.31 | $ | 0.95 |
9. Repurchase of Common Stock
On February 28, 2022, our Board of Directors approved a $5.0 billion share repurchase program. The program had $3.0 billion remaining available for repurchases as of May 2, 2026. There is no expiration date governing the period over which we can repurchase shares under this authorization.
There were no share repurchases during the three months ended May 2, 2026. Information regarding the shares we repurchased and retired in the prior year was as follows ($ and shares in millions, except per share amounts):
| Three Months Ended May 3, 2025 | |||||||||||||||||||||||
| Total cost of shares repurchased | $ | 100 | |||||||||||||||||||||
| Average price per share | $ | 64.39 | |||||||||||||||||||||
| Number of shares repurchased and retired | 1.6 |
10. Contingencies
We are involved in a number of legal proceedings. Where appropriate, we have made accruals with respect to these matters, which are reflected on our Condensed Consolidated Financial Statements. However, there are cases where liability is not probable or the amount cannot be reasonably estimated and, therefore, accruals have not been made. We provide disclosure of matters where we believe it is reasonably possible the impact may be material to our Condensed Consolidated Financial Statements.
11. Segments
Revenue Category Reclassification
Beginning in the first quarter of fiscal 2027, we reclassified certain amounts within our revenue categories to better align with management's current view of the business. The reclassification primarily relates to credit card revenue and digital content revenue (including digital gaming, software and subscriptions) that were previously included in various product revenue categories and, following the reclassification, are now included within services revenue. The reclassification impacts only the presentation of revenue by category and does not affect previously reported total revenue, net earnings or cash flows.
The key components of each revenue category are now as follows:
-
Computing and Mobile Phones** - computing (including desktops, notebooks and peripherals), mobile phones (including related mobile network carrier commissions), networking, tablets (including e-readers) and wearables (including smartwatches);
-
Consumer Electronics** - digital imaging, health and fitness products, home theater (including accessories, soundbars and televisions), portable audio (including headphones and portable speakers) and smart home;
-
Appliances** - large appliances (including dishwashers, laundry, ovens and refrigerators) and small appliances (including blenders, coffee makers, vacuums and personal care);
-
Entertainment** - drones, gaming (including hardware, peripherals and certain software, as well as augmented reality glasses), toys and virtual reality;
-
Services** - advertising, credit card revenue, digital content (including digital gaming, software and subscriptions), fulfillment, health-related services, installation, marketplace commissions, memberships, repair, technical support and warranty-related services; and
-
Other** - other product offerings (including baby, food and beverage and outdoor living).
Revenue information by segment and category was as follows ($ in millions):
| Three Months Ended | |||||||||||||||||||||||
| May 2, 2026 | May 3, 2025**(1)** | ||||||||||||||||||||||
| Domestic: | |||||||||||||||||||||||
| Computing and Mobile Phones | $ | 3,887 | $ | 3,737 | |||||||||||||||||||
| Consumer Electronics | 2,151 | 2,215 | |||||||||||||||||||||
| Appliances | 841 | 979 | |||||||||||||||||||||
| Services | 786 | 749 | |||||||||||||||||||||
| Entertainment | 548 | 398 | |||||||||||||||||||||
| Other | 36 | 49 | |||||||||||||||||||||
| Total Domestic revenue | 8,249 | 8,127 | |||||||||||||||||||||
| International: | |||||||||||||||||||||||
| Computing and Mobile Phones | 343 | 317 | |||||||||||||||||||||
| Consumer Electronics | 180 | 171 | |||||||||||||||||||||
| Appliances | 53 | 56 | |||||||||||||||||||||
| Services | 49 | 47 | |||||||||||||||||||||
| Entertainment | 51 | 41 | |||||||||||||||||||||
| Other | 11 | 8 | |||||||||||||||||||||
| Total International revenue | 687 | 640 | |||||||||||||||||||||
| Total revenue | $ | 8,936 | $ | 8,767 |
(1)Amounts for the three months ended May 3, 2025, have been recast to conform to the current presentation. See Revenue Category Reclassification, above, for additional information.
Adjusted operating income by segment and the reconciliation to consolidated earnings before income tax expense and equity in loss of affiliates were as follows ($ in millions):
| Three Months Ended | |||||||||||||||||||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||||||||||||||||||
| Domestic**(1)** | International | Total | Domestic**(1)** | International | Total | ||||||||||||||||||||||||||||||
| Revenue | $ | 8,249 | $ | 687 | $ | 8,936 | $ | 8,127 | $ | 640 | $ | 8,767 | |||||||||||||||||||||||
| Cost of sales | 6,295 | 539 | 6,834 | 6,219 | 499 | 6,718 | |||||||||||||||||||||||||||||
| Adjusted SG&A(2) | 1,596 | 143 | 1,739 | 1,579 | 137 | 1,716 | |||||||||||||||||||||||||||||
| Adjusted operating income | $ | 358 | $ | 5 | 363 | $ | 329 | $ | 4 | 333 | |||||||||||||||||||||||||
| Restructuring charges | (9) | 109 | |||||||||||||||||||||||||||||||||
| Intangible asset amortization | 2 | 5 | |||||||||||||||||||||||||||||||||
| Operating income | 370 | 219 | |||||||||||||||||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||||||||||||||
| Investment income and other | 19 | 15 | |||||||||||||||||||||||||||||||||
| Interest expense | (11) | (12) | |||||||||||||||||||||||||||||||||
| Earnings before income tax expense and equity in loss of affiliates | $ | 378 | $ | 222 |
(1)Domestic segment Adjusted operating income includes certain operations that are based in foreign tax jurisdictions and primarily relate to sourcing products into the U.S.
(2)Adjusted SG&A excludes amortization of definite-lived intangible assets associated with acquisitions.
Cash flow and other expense information by segment was as follows ($ in millions):
| Three Months Ended | |||||||||||||||||||||||
| May 2, 2026 | May 3, 2025 | ||||||||||||||||||||||
| Capital expenditures | |||||||||||||||||||||||
| Domestic | $ | 145 | $ | 150 | |||||||||||||||||||
| International | 15 | 16 | |||||||||||||||||||||
| Total capital expenditures | $ | 160 | $ | 166 | |||||||||||||||||||
| Depreciation and amortization | |||||||||||||||||||||||
| Domestic | $ | 182 | $ | 201 | |||||||||||||||||||
| International | 12 | 10 | |||||||||||||||||||||
| Total depreciation and amortization | $ | 194 | $ | 211 |
Asset information by segment was as follows ($ in millions):
| May 2, 2026 | January 31, 2026 | May 3, 2025 | |||||||||||||||
| Domestic | $ | 13,586 | $ | 13,407 | $ | 12,835 | |||||||||||
| International | 1,304 | 1,263 | 1,293 | ||||||||||||||
| Total assets | $ | 14,890 | $ | 14,670 | $ | 14,128 |
Previous: Cover and table of contents · Next: Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations